3036 Evaluation of a new regional pathway for Medicines Optimisation in Older People (MOOP) medicines adherence pharmacist optimising

Abstract Introduction The Regional Medicines Optimisation in Older People (MOOP) Medicines Adherence Pharmacy team review medicines for older people at home across Northern Ireland (NI). Northern Ireland Ambulance Service (NIAS) are often first responders to older people at home requiring medical attention, and identify medicines adherence issues, which may lead to Emergency Department presentation and hospitalisation if not addressed. Method In July 2023, Belfast HSC Trust MOOP pharmacy team led a new regional pathway pilot to enable NIAS first responders to refer older people for medicines adherence review. Inclusion Criteria: Pharmacist Interventions were graded using Eadon grading scale (1), & ScHARR cost avoidance estimates (2,3) which defines costs related to Adverse Drg Events (ADEs) were applied. Results n = 12 patients: Reason for referral by NIAS included people with multiple unused medicine compliance aids, suboptimal pain management, or confused about their medicines. Time spent by pharmacist ranged from 60 to 400 minutes (average 170 minutes per patient). Clinical pharmacist interventions (n = 62) included blood pressure measurement, deprescribing of inappropriate medicines, optimising pain management, & supply of adherence aids. 97% of clinical interventions were potentially significant at Eadon grade 4 (n = 60). Total cost avoidance due to pharmacist interventions was £5678 to £12,867, with Invest to Save £6.40 to £14.52 for every pound invested. Conclusion A collaborative pathway between medicines optimisation in older people pharmacy service and the Northern Ireland Ambulance Service, led to cost effective improvements in medicines optimisation for older people. References 1. Eadon, H. 1992 Assessing the quality of ward pharmacists’ interventions. Int J Pharm Pract. 1(3): 145–147. 2. Karnon, J., et al. 2008. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy 2008; 13: 85–91. 3. Mair, A., et al. 2023 iSimpathy Evaluation Report Edinburgh ISBN978–1–3999-6298-8.

Authors

Institutions

Publication Details

Journal
Age and Ageing
Published
2025-07-01
DOI
https://doi.org/10.1093/ageing/afaf133.004
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

3036 Evaluation of a new regional pathway for Medicines Optimisation in Older People (MOOP) medicines adherence pharmacist optimising

Karen Miller, Carmel Darcy, Paul F. Galbraith, Chris McGuigan et al.
Age and Ageing
Pharmaceutical Practices and Patient Outcomes
article

3036 Evaluation of a new regional pathway for Medicines Optimisation in Older People (MOOP) medicines adherence pharmacist optimising

Karen Miller, Carmel Darcy, Paul F. Galbraith, Chris McGuigan, Karl Bloomer, Samuel Johnston, A. J. Cunningham, Jonathan D. Agnew, J. Herbert Patterson, Paula Crawford, C Stevenson, Hilary McKee, J McGennity, P Tennyson
article en

Abstract

Abstract Introduction The Regional Medicines Optimisation in Older People (MOOP) Medicines Adherence Pharmacy team review medicines for older people at home across Northern Ireland (NI). Northern Ireland Ambulance Service (NIAS) are often first responders to older people at home requiring medical attention, and identify medicines adherence issues, which may lead to Emergency Department presentation and hospitalisation if not addressed. Method In July 2023, Belfast HSC Trust MOOP pharmacy team led a new regional pathway pilot to enable NIAS first responders to refer older people for medicines adherence review. Inclusion Criteria: Pharmacist Interventions were graded using Eadon grading scale (1), & ScHARR cost avoidance estimates (2,3) which defines costs related to Adverse Drg Events (ADEs) were applied. Results n = 12 patients: Reason for referral by NIAS included people with multiple unused medicine compliance aids, suboptimal pain management, or confused about their medicines. Time spent by pharmacist ranged from 60 to 400 minutes (average 170 minutes per patient). Clinical pharmacist interventions (n = 62) included blood pressure measurement, deprescribing of inappropriate medicines, optimising pain management, & supply of adherence aids. 97% of clinical interventions were potentially significant at Eadon grade 4 (n = 60). Total cost avoidance due to pharmacist interventions was £5678 to £12,867, with Invest to Save £6.40 to £14.52 for every pound invested. Conclusion A collaborative pathway between medicines optimisation in older people pharmacy service and the Northern Ireland Ambulance Service, led to cost effective improvements in medicines optimisation for older people. References 1. Eadon, H. 1992 Assessing the quality of ward pharmacists’ interventions. Int J Pharm Pract. 1(3): 145–147. 2. Karnon, J., et al. 2008. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy 2008; 13: 85–91. 3. Mair, A., et al. 2023 iSimpathy Evaluation Report Edinburgh ISBN978–1–3999-6298-8.

Age and AgeingVol. 54(Supplement_2)
Belfast Health and Social Care Trust (GB), Northern Health and Social Care Trust (GB), Western Health and Social Care Trust (GB), Southern Health and Social Care Trust (GB), South Eastern Health and Social Care Trust (GB)
Openalex Percentile: Top 81%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.